Details of the Drug Reposition
General Information of This Drug (ID: DMVJMF1)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms | Klerval; RPR-109039; N-Ethyl-N-[4-(4-piperidyl)butyryl]-glycyl-L-aspartyl-L-(3-cyclohexyl)alaninamide | |||||
| Structure | 
                    ![]()  | 
            |||||
| 3D MOL is unavailable | 2D MOL | |||||
Information on Drug Reposition of This Drug
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 
                     1 Phase 1 Indication(s) 
                 | 
                
                                                
  | 
            |||||||||||||||||||||||||
| 
                     1 Discontinued in Phase 2 Indication(s) 
                 | 
                
                                                
  | 
            |||||||||||||||||||||||||
References

